FDA Designates VERTANICAL Full‑Spectrum Hemp Extract as Breakthrough Therapy — Non‑Opioid Treatment for Chronic Low Back Pain
The FDA has granted Breakthrough Therapy designation to VER-01, a full‑spectrum hemp extract developed by German company VERTANICAL. As a first‑in‑class, non‑opioid therapy for chronic low back pain, VER-01 is expected to mark an important milestone in the clinical development of hemp/cannabis‑based pharmaceuticals.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
prnewswire.com
CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.
Original Link
https://www.prnewswire.com/news-releases/fda-grants-breakthrough-therapy-designation-to-vertanicals-ver-01-a-first-in-class-non-opioid-investigational-treatment-for-chronic-low-back-pain-302774617.html